20 Hrs
المصدر:
Financial Times
Novartis stock dips after drug trial failure
A Swiss drugmaker's treatment pipeline has faced a setback, representing a new challenge for the company's development efforts. Specific details about the nature of the setback or its impact were not provided.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading